bioRxivBiochemistryPreprint
Tannic Acid Inhibits α-Synuclein Amyloid Fibril Formation via Binding to the Monomer N-terminal Domain
Abstract
-Synuclein (S) is an intrinsically disordered protein (IDP) that aggregates into amyloid fibrils during the progression of Parkinsons Disease and other synucleinopathies. The N-terminal domain (residues 1-60) is now understood to play a critical role in the initial nucleation of aggregation, as well as a pivotal role in the monomer-fibril interaction underlying amyloid seeding. Here we report on the interaction between S and the polyphenol tannic acid (TA), where a combination of solution NMR, atomic force microscopy (AFM), and ThT assays have identified that TA targets the S N-terminal domain to inhibit amyloid fibril formation in a pH dependent manner. This work highlights the importance of targeting the N-terminus of S to arrest fibril formation, and suggests the importance of including polyphenolic moieties in future amyloid inhibitors.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NMR unveils an N-terminal interaction interface on acetylated-α-synuclein monomers for recruitment to fibrils
- Residues 2-7 of alpha-synuclein regulate amyloid formation via lipid-dependent and -independent pathways
Katherine M. Dewison, Benjamin Rowlinson, … Sheena E. Radford·Proceedings of the National Academy of SciencesPeer-reviewed·Aug 12, 2024
- Suppression and modulation mechanism underlying the flavonoid-induced inhibition of fibrillation of α-synuclein
Geetika Verma, Rajiv Bhat·bioRxiv·Aug 21, 2025
- A structural and kinetic link between membrane association and amyloid fibril formation of α-Synuclein
T. Viennet, M. M. Wördehoff, … M. Etzkorn·bioRxiv·Aug 8, 2017
- An engineered monomer binding-protein for α-synucleinefficiently inhibits the proliferation of amyloid fibrils
E. D. Agerschou, T. Saridaki, … A. K. Buell·bioRxiv·Mar 5, 2019
- N-terminal acetylation reduces α-synuclein pathology in models of Parkinson's disease
Esther del Cid‐Pellitero, Thomas Goiran, … Edward A. Fon·Neurobiology of DiseasePeer-reviewed·Jun 11, 2026